loading page

Manifestations and outcomes of intracerebral hemorrhage during COVID‐19 pandemic in China: a multicenter, longitudinal cohort study
  • +9
  • Quanwei He,
  • Yan Wan,
  • Shaoli Chen,
  • Man Li,
  • Yuanpeng Xia,
  • Lei Zhang,
  • Zhou Sun,
  • Xiaolu Chen,
  • David Wang,
  • Xingquan Zhao,
  • Yongjun Wang,
  • Bo Hu
Quanwei He
Huazhong University of Science and Technology Tongji Medical College

Corresponding Author:hequanwei2008@126.com

Author Profile
Yan Wan
Huazhong University of Science and Technology Tongji Medical College
Author Profile
Shaoli Chen
Huazhong University of Science and Technology Tongji Medical College
Author Profile
Man Li
Huazhong University of Science and Technology Tongji Medical College
Author Profile
Yuanpeng Xia
Huazhong University of Science and Technology Tongji Medical College
Author Profile
Lei Zhang
Huazhong University of Science and Technology Tongji Medical College
Author Profile
Zhou Sun
Huazhong University of Science and Technology Tongji Medical College
Author Profile
Xiaolu Chen
Huazhong University of Science and Technology Tongji Medical College
Author Profile
David Wang
Barrow Neurological Institute
Author Profile
Xingquan Zhao
Beijing Tiantan Hospital
Author Profile
Yongjun Wang
Beijing Tiantan Hospital
Author Profile
Bo Hu
Huazhong University of Science and Technology Tongji Medical College
Author Profile

Abstract

Background: We just right were carrying out a multicenter cohort study about ICH when COVID-19 broke out in Wuhan,and we wondered whether COVID-19 pandemic was associated with the manifestations and outcomes of intracerebral hemorrhage (ICH). Methods: Acute ICH patients before (1/12/2018-30/11/2019) and during COVID-19(1/12/2019-30/11/2020) pandemic at 31 centers in China, were entered into the analysis. Demographic information, clinical manifestations and outcomes were collected and compared between the two groups. Results: From December 1, 2018 to November 30, 2020, a total of 3460 patients with ICH were enrolled and eventually analyzed. Results showed that patients with ICH were more likely to be older, have higher systolic blood pressure (BP) (P<0.001), diastolic-BP (P=0.002), higher admission NIHSS score (P=0.039) and higher fasting blood glucose (P=0.003) during COVID-19 pandemic compared with before. After adjusting age, gender, COVID-19 pandemic was associated with 3-month poor outcome (OR adjusted = 1.206, 95%CI: 1.043-1.395) and 3-month mortality (OR adjusted = 1.711, 95%CI: 1.428-2.050) after ICH onset. Conclusions: COVID-19 pandemic deteriorated the manifestations and outcomes of ICH.